The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...
Michael Mager of Precision Neuroscience, a brain implant startup rival to Elon Musk's Neuralink, sounds off on the future of ...
Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...
The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...
Disruptedcategory Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant September 18, 2024 Healthcare & Pharmaceuticalscategory Musk's Neuralink says second trial implant ...
Michelle Tarver, MD, PhD, a 15-year veteran of the agency, is stepping into a pivotal role as the new director of the FDA's device division, taking over for Jeffrey Shuren, MD. Dr. Shuren's tenure was ...
It is not known how many patients the FDA ultimately approved. Musk has grand ambitions for Neuralink, saying it would facilitate speedy surgical insertions of its chip devices to treat conditions ...
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical ...
Future of Healthcategory Musk's Neuralink says tiny wires of brain chip in first patient now stable July 11, 2024 Future of Healthcategory US FDA approves expanded use of Sarepta's Duchenne gene ...
Last month’s NIH/FDA workshop about Clinical Outcomes Assessments may represent ... or in the more distant future, deliver a ...